COURFAZA Trademark

Trademark Overview


On Tuesday, April 30, 2019, a trademark application was filed for COURFAZA with the United States Patent and Trademark Office. The USPTO has given the COURFAZA trademark a serial number of 88408756. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, July 8, 2024. This trademark is owned by Johnson & Johnson. The COURFAZA trademark is filed in the Pharmaceutical Products category with the following description:

vaccines; anxiolytics

General Information


Serial Number88408756
Word MarkCOURFAZA
Filing DateTuesday, April 30, 2019
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Goods and Servicesvaccines; anxiolytics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events


Event DateEvent Description
Friday, May 3, 2019NEW APPLICATION ENTERED
Thursday, May 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 11, 2019ASSIGNED TO EXAMINER
Monday, July 15, 2019SUSPENSION LETTER WRITTEN
Monday, July 15, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 31, 2020ASSIGNED TO LIE
Friday, February 7, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 26, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, July 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 31, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 8, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, October 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, October 12, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 27, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 27, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, April 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 22, 2024SOU EXTENSION 1 FILED
Monday, January 22, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024SOU EXTENSION 2 GRANTED
Monday, July 8, 2024SOU EXTENSION 2 FILED
Thursday, December 12, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords


courfaza anxiolytics vaccines